Related references
Note: Only part of the references are listed.Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
Michael J. Christie et al.
SCIENCE IMMUNOLOGY (2021)
Autoimmune haemolytic anaemia associated with COVID-19 infection
Gregory Lazarian et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjorn Berentsen
FRONTIERS IN IMMUNOLOGY (2020)
Immune Thrombocytopenic Purpura in a Patient with Covid-19
Abrar-Ahmad Zulfiqar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C. Mastellos et al.
CLINICAL IMMUNOLOGY (2020)
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study
Djillali Annane et al.
ECLINICALMEDICINE (2020)
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
Alexander Roth et al.
BLOOD (2019)
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jaeger et al.
BLOOD (2019)
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjorn Berentsen et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial
Alexander Roeth et al.
BLOOD ADVANCES (2018)
Cold agglutinin disease
Sigbjorn Berentsen
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Cholangiocarcinoma Presenting as Metastases to the Cervical Spine
Trilokesh Kidambi et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Share Paper
